Summary: Several prominent biologists and medical experts have recently published findings suggesting there is some hope for extending life spans dramatically via medical interventions.
Original author and publication date: Adrian Raftery – August 10, 2021
Futurizonte Editor’s Note: There was a time 2000 years ago when a person was thought to be “very old” at 40. Perhaps there is an opportunity to extend active, healthy human life span.
From the article:
When Jeanne Calment of France died in 1997 at the age of 122 years and 164 days, she set a record for oldest human. That record still stands.
As statisticians who study demography, we expect that record will be broken by 2100.
We study the maximum human life span using a data-driven approach. Our peer-reviewed study, published in June 2021, models and combines two key components: how the risk of dying flattens after age 110, and growth in the number of people to reach age 110 this century.
Our analysis of these two factors, which we did before the COVID-19 pandemic, suggests it’s nearly inevitable that someone will break Calment’s record during the 21st century, with an 89% chance that someone will live to at least 126, but only a 3% chance that someone will reach age 132.
Debate around maximum human life span
Scientists are actively debating whether there is a fixed limit to the human life span.
Some biologists think the data shows that aging is not a disease that can be treated, but instead an inevitable process that cannot be fully stopped, whether through medical breakthroughs or other means. Some demographers have argued that there is a natural limit to life expectancy, implying that maximum ages will level off as well.
But others think there’s good evidence that life spans will continue to lengthen – at least for a lucky few. Several prominent biologists and medical experts have recently published findings suggesting there is some hope for extending life spans dramatically via medical interventions.
Ultrawealthy tech titans like Tesla’s Elon Musk and Google co-founder Sergey Brin are investing heavily in such research.